Pages that link to "Q36326103"

The following pages link to Co-delivery of camptothecin and curcumin by cationic polymeric nanoparticles for synergistic colon cancer combination chemotherapy. (Q36326103):

Displaying 23 items.

• Recent advances in orally administered cell-specific nanotherapeutics for inflammatory bowel disease (Q28073219) (← links)
• Development of antiproliferative long-circulating liposomes co-encapsulating doxorubicin and curcumin, through the use of a quality-by-design approach. (Q33739032) (← links)
• Combination Therapy for Ulcerative Colitis: Orally Targeted Nanoparticles Prevent Mucosal Damage and Relieve Inflammation (Q37469872) (← links)
• Dual-drug loaded nanoformulation with a galactosamine homing moiety for liver-targeted anticancer therapy (Q38762779) (← links)
• Nanoparticle-mediated co-delivery of chemotherapeutic agent and siRNA for combination cancer therapy (Q38874499) (← links)
• Nanoformulations for combination or cascade anticancer therapy. (Q39380111) (← links)
• Glycyrrhetinic acid-functionalized mesoporous silica nanoparticles as hepatocellular carcinoma-targeted drug carrier. (Q41095468) (← links)
• Oral delivery of curcumin via porous polymeric nanoparticles for effective ulcerative colitis therapy. (Q46272530) (← links)
• iRGD-functionalized PEGylated nanoparticles for enhanced colon tumor accumulation and targeted drug delivery. (Q47815925) (← links)
• Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis. (Q47980720) (← links)
• Recent advances in co-delivery systems based on polymeric nanoparticle for cancer treatment (Q49714833) (← links)
• Co-Delivery of Curcumin and Chrysin by Polymeric Nanoparticles Inhibit Synergistically Growth and hTERT Gene Expression in Human Colorectal Cancer Cells. (Q50224155) (← links)
• Dual-targeting nanoparticles: co-delivery of curcumin and 5-fluorouracil for synergistic treatment of hepatocarcinoma (Q58617165) (← links)
• Synergic Activity Against MCF-7 Breast Cancer Cell Growth of Nanocurcumin-Encapsulated and Cisplatin-Complexed Nanogels (Q60950230) (← links)
• Curcumin Nanoformulations for Colorectal Cancer: A Review (Q64062604) (← links)
• CXCR4-targeted liposomal mediated co-delivery of pirfenidone and AMD3100 for the treatment of TGFβ-induced HSC-T6 cells activation (Q64085690) (← links)
• Liver-targeted liposomes for codelivery of curcumin and combretastatin A4 phosphate: preparation, characterization, and antitumor effects (Q64115606) (← links)
• Evaluation of the PEG Density in the PEGylated Chitosan Nanoparticles as a Drug Carrier for Curcumin and Mitoxantrone. (Q64882563) (← links)
• Dual Interactions of Amphiphilic Gelatin Copolymer and Nanocurcumin Improving the Delivery Efficiency of the Nanogels. (Q64969817) (← links)
• Curcumin- and Piperine-Loaded Emulsomes as Combinational Treatment Approach Enhance the Anticancer Activity of Curcumin on HCT116 Colorectal Cancer Model (Q89967472) (← links)
• Synergistically Enhanced Inhibitory Effects of Pullulan Nanoparticle-Mediated Co-Delivery of Lovastatin and Doxorubicin to Triple-Negative Breast Cancer Cells (Q90102543) (← links)
• Curcumin Combination Chemotherapy: The Implication and Efficacy in Cancer (Q91802119) (← links)
• Current trends and challenges in cancer management and therapy using designer nanomaterials (Q91871531) (← links)